Literature DB >> 17674042

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

G Rindi1, G Klöppel, A Couvelard, P Komminoth, M Körner, J M Lopes, A-M McNicol, O Nilsson, A Perren, A Scarpa, J-Y Scoazec, B Wiedenmann.   

Abstract

Criteria for the staging and grading of neuroendocrine tumors (NETs) of midgut and hindgut origin were established at the second Consensus Conference in Frascati (Rome) organized by the European Neuroendocrine Tumor Society (ENETS). The proposed tumor-node-metastasis (TNM) classifications are based on the recently published ENETS Guidelines for the Diagnosis and Treatment of gastroenteropancreatic NETs and follow our previous proposal for foregut tumors. The new TNM classifications for NETs of the ileum, appendix, colon, and rectum, and the grading system were designed, discussed, and consensually approved by all conference participants. These proposals need to be validated and are meant to help clinicians in the stratification, treatment and follow-up of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17674042     DOI: 10.1007/s00428-007-0452-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

Authors:  G Rigaud; E Missiaglia; P S Moore; G Zamboni; M Falconi; G Talamini; A Pesci; A Baron; D Lissandrini; G Rindi; P Grigolato; P Pederzoli; A Scarpa
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

Review 2.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

Review 3.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

5.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

6.  Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

Authors:  Susanne Van Eeden; Pascal F H J Quaedvlieg; Babs G Taal; G Johan A Offerhaus; Cornelis B H W Lamers; Marie-Louise F Van Velthuysen
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

Review 7.  Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.

Authors:  G Rindi; V Villanacci; A Ubiali
Journal:  Digestion       Date:  2000       Impact factor: 3.216

8.  Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.

Authors:  F Gibril; J L Doppman; J C Reynolds; C C Chen; V E Sutliff; F Yu; J Serrano; D J Venzon; R T Jensen
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

Review 9.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  265 in total

Review 1.  ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.

Authors:  Valentina Ambrosini; Davide Campana; Paola Tomassetti; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

2.  [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].

Authors:  G Klöppel; G Rindi; A Perren; P Komminoth; D S Klimstra
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

3.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

4.  The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.

Authors:  Günter Klöppel; Guido Rindi; Aurel Perren; Paul Komminoth; David S Klimstra
Journal:  Virchows Arch       Date:  2010-04-27       Impact factor: 4.064

Review 5.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

6.  KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Authors:  Federica Grillo; Luca Valle; Diego Ferone; Manuela Albertelli; Maria Pia Brisigotti; Giuseppe Cittadini; Alessandro Vanoli; Roberto Fiocca; Luca Mastracci
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

Review 7.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 8.  Current state of knowledge on neuroendocrine small bowel tumours: non-systematic review of the literature based on one case.

Authors:  Nicolae Irinel Simion; Valentin Muntean; Ovidiu Fabian
Journal:  BMJ Case Rep       Date:  2013-01-17

9.  Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival.

Authors:  Kendall J Keck; Allen Choi; Jessica E Maxwell; Guiying Li; Thomas M O'Dorisio; Patrick Breheny; Andrew M Bellizzi; James R Howe
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

10.  Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.

Authors:  Michelle Kang Kim; Richard R P Warner; Sasan Roayaie; Noam Harpaz; Stephen C Ward; Steven Itzkowitz; Juan P Wisnivesky
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.